Genvira and Labskin receive £1.2 Million to advance immunotherapies for malignant melanoma, supported by the National Research Council of Canada and Innovate UK.
Amount Raised
£1.2 Million
Round Type
Seed
Investors
Description
Genvira and Labskin announce a collaborative project to develop novel immunotherapies for malignant melanoma, receiving up to £1.2 million in funding through the Canada–UK Biomanufacturing program. Labskin will develop a 3D human skin model for testing vaccine candidates, while Genvira will provide viral vector and gene delivery platforms. The NRC will incorporate mRNA technologies to create targeted immunotherapies. This partnership addresses the urgent need for effective cancer vaccines.
Quick answer
Genvira Biosciences raised £1.2 Million in a Seed round, dated July 31, 2025. Investors: Innovate UK and National Research Council Of Canada.
- How much did Genvira Biosciences raise?
- Genvira Biosciences raised £1.2 Million in a Seed round on July 31, 2025.
- Who invested in Genvira Biosciences?
- Innovate UK and National Research Council Of Canada are named as investors in this round.
- What does Genvira Biosciences do?
- Genvira Bioscience is a Canadian biotechnology company focused on designing and developing viral vector platforms for use in gene therapies, cancer vaccines, and regenerative medicine.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Genvira Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Lila Sciences raised $235M (Funding Round) on September 13, 2025.
- Greenbutts raised $198K on September 12, 2025.
- Mevaldi raised an undisclosed amount (Funding Round) on September 12, 2025.
- Claris Biotherapeutics raised $2.3M (Seed) on September 12, 2025.
- OpenHealth Technologies raised $3M (Seed) on September 11, 2025.
- Sophont raised $9.2M (Seed) on September 11, 2025.
Who to call at Genvira Biosciences, and when
A new round usually means Genvira Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Genvira Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genvira Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genvira Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genvira Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Genvira Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.